These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 20177426)

  • 1. Repeat expansion disease: progress and puzzles in disease pathogenesis.
    La Spada AR; Taylor JP
    Nat Rev Genet; 2010 Apr; 11(4):247-58. PubMed ID: 20177426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To be or not to be an aggregate.
    Nasir J
    Clin Genet; 1999 Jan; 55(1):9-10. PubMed ID: 10066024
    [No Abstract]   [Full Text] [Related]  

  • 4. Anomalous rapid electrophoretic mobility of DNA containing triplet repeats associated with human disease genes.
    Chastain PD; Eichler EE; Kang S; Nelson DL; Levene SD; Sinden RR
    Biochemistry; 1995 Dec; 34(49):16125-31. PubMed ID: 8519769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association of the SCA1 (CAG)31 allele with Huntington's disease, myotonic dystrophy type 1 and spinocerebellar ataxia type 3.
    Hellenbroich Y; Kaulich M; Opitz S; Schwinger E; Zühlke C
    Psychiatr Genet; 2004 Jun; 14(2):61-3. PubMed ID: 15167689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1.
    Zoghbi HY; Orr HT
    J Biol Chem; 2009 Mar; 284(12):7425-9. PubMed ID: 18957430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mosaicism of the CAG repeat in CNS tissue in relation to age at death in spinocerebellar ataxia type 1 and Machado-Joseph disease patients.
    Maciel P; Lopes-Cendes I; Kish S; Sequeiros J; Rouleau GA
    Am J Hum Genet; 1997 Apr; 60(4):993-6. PubMed ID: 9106546
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeting several CAG expansion diseases by a single antisense oligonucleotide.
    Evers MM; Pepers BA; van Deutekom JC; Mulders SA; den Dunnen JT; Aartsma-Rus A; van Ommen GJ; van Roon-Mom WM
    PLoS One; 2011; 6(9):e24308. PubMed ID: 21909428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diseases of unstable repeat expansion: mechanisms and common principles.
    Gatchel JR; Zoghbi HY
    Nat Rev Genet; 2005 Oct; 6(10):743-55. PubMed ID: 16205714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis.
    Lee T; Li YR; Chesi A; Hart MP; Ramos D; Jethava N; Hosangadi D; Epstein J; Hodges B; Bonini NM; Gitler AD
    Neurology; 2011 Jun; 76(24):2062-5. PubMed ID: 21562248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canadian Association of Neurosciences Review: polyglutamine expansion neurodegenerative diseases.
    Truant R; Raymond LA; Xia J; Pinchev D; Burtnik A; Atwal RS
    Can J Neurol Sci; 2006 Aug; 33(3):278-91. PubMed ID: 17001815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New insights in the molecular genetics and pathophysiology of hereditary ataxias].
    Bürk K; Klockgether T; Dichgans J
    Nervenarzt; 1999 Jun; 70(6):491-5. PubMed ID: 10412692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA toxicity is a component of ataxin-3 degeneration in Drosophila.
    Li LB; Yu Z; Teng X; Bonini NM
    Nature; 2008 Jun; 453(7198):1107-11. PubMed ID: 18449188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA toxicity in non-coding repeat expansion disorders.
    Swinnen B; Robberecht W; Van Den Bosch L
    EMBO J; 2020 Jan; 39(1):e101112. PubMed ID: 31721251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1.
    Ju H; Kokubu H; Lim J
    Mol Neurobiol; 2014 Dec; 50(3):866-874. PubMed ID: 24752589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAG repeat instability, cryptic sequence variation and pathogeneticity: evidence from different loci.
    Frontali M; Novelletto A; Annesi G; Jodice C
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1089-94. PubMed ID: 10434311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.
    Chen HK; Fernandez-Funez P; Acevedo SF; Lam YC; Kaytor MD; Fernandez MH; Aitken A; Skoulakis EM; Orr HT; Botas J; Zoghbi HY
    Cell; 2003 May; 113(4):457-68. PubMed ID: 12757707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-protein interactions in unstable microsatellite diseases.
    Mohan A; Goodwin M; Swanson MS
    Brain Res; 2014 Oct; 1584():3-14. PubMed ID: 24709120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract.
    Yue S; Serra HG; Zoghbi HY; Orr HT
    Hum Mol Genet; 2001 Jan; 10(1):25-30. PubMed ID: 11136710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaleidoscopic protein-protein interactions in the life and death of ataxin-1: new strategies against protein aggregation.
    de Chiara C; Pastore A
    Trends Neurosci; 2014 Apr; 37(4):211-8. PubMed ID: 24636457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.